Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AQUILA BIOPHARMACEUTICALS INC (AQLA) -- Ignore unavailable to you. Want to Upgrade?

To: Harry J. who wrote (39)	6/8/2000 12:07:00 PM
From: RWReeves	Read Replies (1) \| Respond to of 45

Looks like AQLA is pretty much oversold. They still have a decent portfolio of approved products that should generate revenues for them. Quarter to quarter performance for 1999 vs. 2000 expenses stable at 3 million while revenues went to 1.4 so question is can they breakeven before running out of money? I'm wondering why the approved products are not "bankable" and they are looking for a sugardaddy. At a market cap of 28 million, 8 million of that cash as of last quarterly report looks like a reasonably attractive munch. They should be worth well over that. RWR